Literature DB >> 16754986

Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.

Jun Saito1, Mototsugu Yamada, Takashi Watanabe, Hideo Kitagawa, Yasuo Takeuchi.   

Abstract

The enoyl-acyl carrier protein (ACP) reductase from Streptococcus pneumoniae (FabK; EC 1.3.1.9) is responsible for catalyzing the final step in each elongation cycle of fatty-acid biosynthesis. Selenomethionine-substituted FabK was purified and crystallized by the hanging-drop vapour-diffusion method at 277 K. The crystal belongs to space group P2(1), with unit-cell parameters a = 50.26, b = 126.70, c = 53.63 A, beta = 112.46 degrees . Diffraction data were collected to 2.00 A resolution using synchrotron beamline BL32B2 at SPring-8. Two molecules were estimated to be present in the asymmetric unit, with a solvent content of 45.1%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754986      PMCID: PMC2243098          DOI: 10.1107/S1744309106017039

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  16 in total

1.  A triclosan-resistant bacterial enzyme.

Authors:  R J Heath; C O Rock
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

2.  Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis.

Authors:  R J Heath; Y T Yu; M A Shapiro; E Olson; C O Rock
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

Review 3.  Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis.

Authors:  C O Rock; J E Cronan
Journal:  Biochim Biophys Acta       Date:  1996-07-12

4.  Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus.

Authors:  C Slater-Radosti; G Van Aller; R Greenwood; R Nicholas; P M Keller; W E DeWolf; F Fan; D J Payne; D D Jaworski
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

Review 5.  Lipid biosynthesis as a target for antibacterial agents.

Authors:  R J Heath; S W White; C O Rock
Journal:  Prog Lipid Res       Date:  2001-11       Impact factor: 16.195

6.  Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.

Authors:  R J Heath; J Li; G E Roland; C O Rock
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

7.  1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI).

Authors:  D A Heerding; G Chan; W E DeWolf; A P Fosberry; C A Janson; D D Jaworski; E McManus; W H Miller; T D Moore; D J Payne; X Qiu; S F Rittenhouse; C Slater-Radosti; W Smith; D T Takata; K S Vaidya; C C Yuan; W F Huffman
Journal:  Bioorg Med Chem Lett       Date:  2001-08-20       Impact factor: 2.823

8.  Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis.

Authors:  A Quémard; J C Sacchettini; A Dessen; C Vilcheze; R Bittman; W R Jacobs; J S Blanchard
Journal:  Biochemistry       Date:  1995-07-04       Impact factor: 3.162

9.  Regulation of fatty acid elongation and initiation by acyl-acyl carrier protein in Escherichia coli.

Authors:  R J Heath; C O Rock
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

10.  1H-15N heteronuclear NMR studies of Escherichia coli thioredoxin in samples isotopically labeled by residue type.

Authors:  D M LeMaster; F M Richards
Journal:  Biochemistry       Date:  1985-12-03       Impact factor: 3.162

View more
  4 in total

1.  Structural characterization of Porphyromonas gingivalis enoyl-ACP reductase II (FabK).

Authors:  Kirk E Hevener; Bernard D Santarsiero; Hyun Lee; Jesse A Jones; Teuta Boci; Michael E Johnson; Shahila Mehboob
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-01-26       Impact factor: 1.056

2.  Expression, purification and characterization of enoyl-ACP reductase II, FabK, from Porphyromonas gingivalis.

Authors:  Kirk E Hevener; Shahila Mehboob; Teuta Boci; Kent Truong; Bernard D Santarsiero; Michael E Johnson
Journal:  Protein Expr Purif       Date:  2012-07-20       Impact factor: 1.650

3.  Crystal structure of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitor.

Authors:  Jun Saito; Mototsugu Yamada; Takashi Watanabe; Maiko Iida; Hideo Kitagawa; Sho Takahata; Tomohiro Ozawa; Yasuo Takeuchi; Fukuichi Ohsawa
Journal:  Protein Sci       Date:  2008-02-27       Impact factor: 6.725

4.  Small-Molecule Inhibition of the C. difficile FAS-II Enzyme, FabK, Results in Selective Activity.

Authors:  Jesse A Jones; Allan M Prior; Ravi K R Marreddy; Rebecca D Wahrmund; Julian G Hurdle; Dianqing Sun; Kirk E Hevener
Journal:  ACS Chem Biol       Date:  2019-06-26       Impact factor: 5.100

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.